Veldoreotide TFA is a somatostatin analogue that acts as an agonist for somatostatin receptors (SSTR) 2, 4, and 5. This compound effectively inhibits growth hormone (GH) secretion in adenomas, demonstrating enhanced efficacy compared to other somatostatin analogues. Additionally, Veldoreotide TFA shows promise as a pain-modulating agent, making it valuable in research applications related to endocrine and pain pathways.
Veldoreotide TFA is a somatostatin analogue that acts as an agonist for somatostatin receptors (SSTR) 2, 4, and 5. This compound effectively inhibits growth hormone (GH) secretion in adenomas, demonstrating enhanced efficacy compared to other somatostatin analogues. Additionally, Veldoreotide TFA shows promise as a pain-modulating agent, making it valuable in research applications related to endocrine and pain pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: